Axogen Assumes Full Distribution Rights for Avance Nerve Graft

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. today announced that it is beginning full distribution of Avance® Nerve Graft, AxoGen’s proprietary human tissue product for use in the reconstruction of damaged peripheral nerves to all surgeons who perform these procedures. Hand and plastic surgeons use AVANCE to provide patients an option in the repair of nerves damaged due to trauma. Previous exclusive distribution relationships in the extremities have been concluded so AxoGen can provide these surgeons with dedicated clinical sales support.